FT. LAUDERDALE, Fla., Jan. 16 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. , a leader in integrated electronic data capture solutions for clinical trials, today announced record breaking results for 2008 in new and repeat business that exceeded original expectations. A record jump of 80% in contracts over 2007 clearly validates OmniComm's position as a major contender in the EDC Marketplace.
"OmniComm has worked hard to build a strong foundation of superior products and services for our customers," said Stephen Johnson, COO of OmniComm. "We recognize the importance of our clients' business and are working diligently to deliver the integrated solutions that they need to succeed. In the very near future, our plans include the introduction of our own IVRS tool, IVRMaster, that will seamlessly integrate with our EDC tool, TrialMaster(R) to offer randomization, ePRO and supply tracking. In early 2009, we will also be releasing our Clinical Data Hub product to offer a more centralized and seamless aggregation of clinical data across multiple systems. This solution will empower our clients to take better control of their data and better leverage core industry standards like CDISC/CDASH, e2b and SDTM."
Added CFO, Ronald Linares, "We are pleased that we were able to increase our revenues during 2008 during what was a difficult year in the macro- economy. More importantly, we have diversified our client mix to include larger Bio-tech firms and have successfully begun deploying our product on a licensed basis."
OmniComm continues to increase its customer base with a strong mix of new customer business coupled with steady, recurring business from its existing loyal customers. The following is a breakdown of business for 2008.
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Chicago, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.
Safe Harbor Disclaimer
Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.
CONTACT: Lizanne Kelley of OmniComm Systems, Inc., +1-954-473-1254
Extension 283, lkelley@omnicomm.com
Web site: http://www.OmniComm.com/
